HK1200933A1 - 改善炎性腸病診斷的方法 - Google Patents
改善炎性腸病診斷的方法Info
- Publication number
- HK1200933A1 HK1200933A1 HK15101185.6A HK15101185A HK1200933A1 HK 1200933 A1 HK1200933 A1 HK 1200933A1 HK 15101185 A HK15101185 A HK 15101185A HK 1200933 A1 HK1200933 A1 HK 1200933A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- methods
- inflammatory bowel
- bowel disease
- disease diagnosis
- improving inflammatory
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54306—Solid-phase reaction mechanisms
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/40—Population genetics; Linkage disequilibrium
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4737—C-reactive protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
- G01N2333/49—Platelet-derived growth factor [PDGF]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
- G01N2333/70525—ICAM molecules, e.g. CD50, CD54, CD102
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
- G01N2333/70542—CD106
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/775—Apolipopeptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/06—Gastro-intestinal diseases
- G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161550293P | 2011-10-21 | 2011-10-21 | |
US201161553853P | 2011-10-31 | 2011-10-31 | |
US201161567096P | 2011-12-05 | 2011-12-05 | |
US201161570271P | 2011-12-13 | 2011-12-13 | |
PCT/US2012/061202 WO2013059732A1 (en) | 2011-10-21 | 2012-10-19 | Methods for improving inflammatory bowel disease diagnosis |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1200933A1 true HK1200933A1 (zh) | 2015-08-14 |
Family
ID=48141435
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15101185.6A HK1200933A1 (zh) | 2011-10-21 | 2015-02-04 | 改善炎性腸病診斷的方法 |
Country Status (10)
Country | Link |
---|---|
US (2) | US8715943B2 (zh) |
EP (1) | EP2769321B1 (zh) |
JP (1) | JP2015502740A (zh) |
AU (1) | AU2012325798B2 (zh) |
CA (1) | CA2852954A1 (zh) |
HK (1) | HK1200933A1 (zh) |
IL (1) | IL232167A0 (zh) |
MX (1) | MX352274B (zh) |
SG (1) | SG11201401536QA (zh) |
WO (1) | WO2013059732A1 (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109476698A (zh) * | 2016-05-20 | 2019-03-15 | 西达-赛奈医疗中心 | 基于基因的炎性肠病诊断 |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010062960A2 (en) | 2008-11-26 | 2010-06-03 | Cedars-Sinai Medical Center | METHODS OF DETERMINING RESPONSIVENESS TO ANTI-TNFα THERAPY IN INFLAMMATORY BOWEL DISEASE |
EP2419529B1 (en) | 2009-04-14 | 2015-05-20 | Nestec S.A. | Inflammatory bowel disease prognostics |
WO2015067913A1 (en) | 2013-11-07 | 2015-05-14 | Diagnodus Limited | Biomarkers |
CN110544517A (zh) | 2011-05-10 | 2019-12-06 | 雀巢产品有限公司 | 用于个体化治疗管理的疾病活动性表征方法 |
CN112870368A (zh) | 2013-03-27 | 2021-06-01 | 西达-赛奈医疗中心 | 通过抑制tl1a的功能和相关信号传导途径来减轻并逆转纤维化和炎症 |
WO2014182689A1 (en) * | 2013-05-06 | 2014-11-13 | Yacyshyn Bruce R | Method of using biomarkers in predicting inflammatory bowel disease |
CN105392780A (zh) * | 2013-05-24 | 2016-03-09 | 雀巢产品技术援助有限公司 | 用于预测肠易激综合征诊断的途径特异性测定 |
EP3022295A4 (en) | 2013-07-19 | 2017-03-01 | Cedars-Sinai Medical Center | Signature of tl1a (tnfsf15) signaling pathway |
US11568982B1 (en) | 2014-02-17 | 2023-01-31 | Health at Scale Corporation | System to improve the logistics of clinical care by selectively matching patients to providers |
EP3167392A4 (en) * | 2014-07-11 | 2018-08-01 | Matatu Inc. | Use of a gut microbiome as a predictor of animal growth or health |
CN104131102B (zh) * | 2014-08-07 | 2016-06-15 | 马飞 | 一种判断nsclc患者对吉非替尼治疗反应性的试剂盒 |
US11809501B2 (en) * | 2014-08-28 | 2023-11-07 | Ebay Inc. | Systems, apparatuses, and methods for providing a ranking based recommendation |
EP3227685A1 (en) * | 2014-12-02 | 2017-10-11 | Nestec S.A. | Methods for establishing a vedolizumab dosing regimen to treat patients with irritable bowel disease |
KR102116485B1 (ko) | 2015-01-20 | 2020-05-28 | 난토믹스, 엘엘씨 | 고분화 방광암의 화학요법에 대한 반응 예측을 위한 시스템들 및 방법들 |
CN107980162A (zh) * | 2015-03-03 | 2018-05-01 | 南托米克斯有限责任公司 | 基于组合的研究建议系统和方法 |
US11037070B2 (en) * | 2015-04-29 | 2021-06-15 | Siemens Healthcare Gmbh | Diagnostic test planning using machine learning techniques |
US11946927B2 (en) | 2016-03-14 | 2024-04-02 | Musidora Biotechnology Llc | Process and system for identifying individuals having a high risk of inflammatory bowel disease and a method of treatment |
US10295527B2 (en) | 2016-03-14 | 2019-05-21 | Bruce Yacyshyn | Process and system for predicting responders and non-responders to mesalamine treatment of ulcerative colitis |
WO2017161342A1 (en) | 2016-03-17 | 2017-09-21 | Cedars-Sinai Medical Center | Methods of diagnosing inflammatory bowel disease through rnaset2 |
JP7111322B2 (ja) | 2016-12-02 | 2022-08-02 | 国立大学法人 東京大学 | 線維化関連分子に対する抗体およびその医療応用 |
EP3554362A4 (en) * | 2016-12-14 | 2020-08-12 | Warren, Tracy | SYSTEM AND METHODS FOR DEVELOPING AND USING A MICROBIOME-BASED ACTION COMPONENT FOR PATIENT HEALTH |
US10409734B1 (en) * | 2017-03-27 | 2019-09-10 | Symantec Corporation | Systems and methods for controlling auxiliary device access to computing devices based on device functionality descriptors |
CN108784666B (zh) * | 2017-05-04 | 2023-01-13 | 深圳市生码医疗科技有限公司 | 连续监测心血管的精准医疗系统及数据处理方法 |
CA3135012A1 (en) | 2017-05-31 | 2018-12-06 | Anjali Jain | Methods for assessing mucosal healing in crohn's disease patients |
US11244454B2 (en) * | 2018-04-03 | 2022-02-08 | Boston Scientific Scimed, Inc. | Systems and methods for diagnosing and/or monitoring disease |
US11058345B2 (en) | 2018-07-05 | 2021-07-13 | Boston Scientific Scimed, Inc. | Devices, systems, and methods for determining inflammation and/or fibrosis |
EP3840831A4 (en) * | 2018-08-21 | 2022-05-11 | Yacyshyn, Bruce, R. | METHOD AND SYSTEM FOR IDENTIFYING INDIVIDUALS AT HIGH RISK OF INFLAMMATORY BOWEL DISEASE, AND METHOD OF TREATMENT |
WO2020113116A1 (en) * | 2018-11-29 | 2020-06-04 | Cedars-Sinai Medical Center | Methods of stratifying and treating a sub-population of inflammatory bowel disease patients |
WO2020117795A1 (en) * | 2018-12-04 | 2020-06-11 | Prometheus Biosciences, Inc. | Assessment and monitoring of mucosal healing in children and adults with crohn's disease |
JP2022523564A (ja) | 2019-03-04 | 2022-04-25 | アイオーカレンツ, インコーポレイテッド | 機械学習を使用するデータ圧縮および通信 |
US20200342958A1 (en) * | 2019-04-23 | 2020-10-29 | Cedars-Sinai Medical Center | Methods and systems for assessing inflammatory disease with deep learning |
WO2020232262A1 (en) * | 2019-05-16 | 2020-11-19 | Procisedx Inc. | Assay detection methods for vcam-1 and calprotectin |
CN110373457B (zh) * | 2019-06-20 | 2023-03-14 | 镇江市第一人民医院 | 一种用于溃疡性结肠炎诊断的mRNA标志物及其应用 |
CN111417124A (zh) * | 2019-06-28 | 2020-07-14 | 西南交通大学 | 在认知无线网络环境下频谱感知的方法 |
US11610679B1 (en) * | 2020-04-20 | 2023-03-21 | Health at Scale Corporation | Prediction and prevention of medical events using machine-learning algorithms |
EP4162076A1 (en) * | 2020-06-03 | 2023-04-12 | Cedars-Sinai Medical Center | Treatments for a sub-population of inflammatory bowel disease patients |
WO2022061346A1 (en) * | 2020-09-16 | 2022-03-24 | Northwestern University | Classification of functional lumen imaging probe data |
WO2022076372A1 (en) * | 2020-10-05 | 2022-04-14 | Cedars-Sinai Medical Center | Methods and systems for stratifying inflammatory bowel disease patients |
US20240044916A1 (en) * | 2020-12-11 | 2024-02-08 | Icahn School Of Medicine At Mount Sinai | Methods of monitoring inflammatory bowel diseases |
CA3208060A1 (en) | 2021-02-17 | 2022-08-25 | Jessie-Farah Fecteau | Anti-cd30l antibodies and uses thereof |
WO2023047257A1 (en) * | 2021-09-22 | 2023-03-30 | Janssen Research & Development, Llc | Automated estimation of ulcerative colitis severity from endoscopy videos using ordinal multi-instance learning |
WO2023147139A1 (en) * | 2022-01-28 | 2023-08-03 | University Of Southern California | Identifying non-disease patients using a disease related assay and analysis in the liquid biopsy |
Family Cites Families (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4277250A (en) | 1979-12-10 | 1981-07-07 | Baylor College Of Medicine | Methods for detecting and quantifying occult blood |
JPH0684970B2 (ja) | 1987-03-31 | 1994-10-26 | 株式会社京都医科学研究所 | 糞便中の潜血検出方法 |
US5081040A (en) | 1987-06-29 | 1992-01-14 | Helena Laboratories Corporation | Composition and kit for testing for occult blood in human and animal excretions, fluids, or tissue matrixes |
US6867195B1 (en) | 1989-03-21 | 2005-03-15 | Vical Incorporated | Lipid-mediated polynucleotide administration to reduce likelihood of subject's becoming infected |
JPH0736013B2 (ja) | 1991-04-27 | 1995-04-19 | 一男 田畑 | 潜血検出用試薬 |
US5885527A (en) | 1992-05-21 | 1999-03-23 | Biosite Diagnostics, Inc. | Diagnostic devices and apparatus for the controlled movement of reagents without membrances |
ES2148251T3 (es) | 1993-03-10 | 2000-10-16 | Cedars Sinai Medical Center | Metodos para detectar selectivamente anticuerpos anticitoplasma de neutrofilos perinucleares de la colitis ulcerosa o colangitis esclerosante primaria. |
US5830675A (en) | 1993-03-10 | 1998-11-03 | Cedars-Sinai Medical Center | Methods for selectively detecting perinuclear anti-neutrophil cytoplasmic antibody of ulcerative colitis, primary sclerosing cholangitis, or type 1 autoimmune hepatitis |
ES2316148T3 (es) | 1994-03-23 | 2009-04-01 | Ohio University | Acidos nucleicos compactados y su suministro a celulas. |
US5972901A (en) | 1994-03-23 | 1999-10-26 | Case Western Reserve University | Serpin enzyme complex receptor--mediated gene transfer |
US5844107A (en) | 1994-03-23 | 1998-12-01 | Case Western Reserve University | Compacted nucleic acids and their delivery to cells |
US6077835A (en) | 1994-03-23 | 2000-06-20 | Case Western Reserve University | Delivery of compacted nucleic acid to cells |
US6074835A (en) | 1996-04-12 | 2000-06-13 | Regents Of The Univ. Of California | Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using histone H1 |
US5916748A (en) | 1996-04-12 | 1999-06-29 | Cedars-Sinai Medical Center | Method of diagnosing a clinical subtype of crohn's disease with features of ulcerative colitis |
US6033864A (en) | 1996-04-12 | 2000-03-07 | The Regents Of The University Of California | Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens |
US5932429A (en) | 1996-04-12 | 1999-08-03 | Cedars-Sinai Medical Center | Methods of diagnosing clinical subtypes of crohn's disease |
US5750479A (en) | 1997-02-14 | 1998-05-12 | Bandon Corp. | Enclosed fluid system conditioner and process therefor |
WO1998037415A1 (en) | 1997-02-20 | 1998-08-27 | The Regents Of The University Of California | ULCERATIVE COLITIS pANCA SECRETORY VESICLE ANTIGEN AND METHODS OF USING SAME |
US6218129B1 (en) | 1998-05-15 | 2001-04-17 | Prometheus Laboratories, Inc. | Inflammatory bowel disease first step assay system |
US6406862B1 (en) | 1998-10-06 | 2002-06-18 | The United States Of America As Represented By The Secretary Of The Army | Dip-stick assay for C-reactive protein |
US6309643B1 (en) | 1999-04-30 | 2001-10-30 | The Regents Of The University Of California | IBD-associated microbial antigens and methods of using same |
AU5161800A (en) | 1999-05-24 | 2000-12-12 | Board Of Regents, The University Of Texas System | Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases |
FR2802536B1 (fr) | 1999-11-23 | 2003-06-13 | Chru Lille | Oligomannosides de synthese, leur preparation et leur utilisation a la detection d'anticorps et a la prevention d'infections |
FR2806739B1 (fr) | 2000-03-27 | 2005-02-18 | Fond Jean Dausset Ceph | Genes impliques dans les maladies inflammatoires de l'intestin et leur utilisation |
US6838250B2 (en) | 2000-03-31 | 2005-01-04 | Ortho-Clinical Diagnostics, Inc. | Immunoassay for C-reactive protein |
US7138237B1 (en) | 2000-05-19 | 2006-11-21 | Cedars-Sinai Medical Center | Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen |
US20020042388A1 (en) | 2001-05-01 | 2002-04-11 | Cooper Mark J. | Lyophilizable and enhanced compacted nucleic acids |
US6821739B2 (en) | 2000-10-13 | 2004-11-23 | The Regents Of The University Of California | Methods of diagnosing and treating Crohn's disease using Pseudomonas antigens |
WO2002032396A2 (en) | 2000-10-16 | 2002-04-25 | Massachusetts Institute Of Technology | Lipid-protein-sugar particles for delivery of nucleic acids |
AU2735002A (en) | 2000-10-30 | 2002-05-15 | Univ Michigan | Nod2 nucleic acids and proteins |
US7060442B2 (en) | 2000-10-30 | 2006-06-13 | Regents Of The University Of Michigan | Modulators on Nod2 signaling |
AU2002243415B2 (en) | 2000-10-30 | 2007-05-24 | Regents Of The University Of Michigan | Nod2 nucleic acids and proteins |
US20050164929A1 (en) | 2000-11-06 | 2005-07-28 | Lupine Logic, Inc. | Methods of preventing and treating inflammatory bowel disease |
EP2071332A1 (en) | 2000-11-14 | 2009-06-17 | Techlab, Inc. | Method for monitoring persons with IBD using total endogeneous lactoferrin as a marker |
US20030203865A1 (en) | 2001-04-30 | 2003-10-30 | Pierrot Harvie | Lipid-comprising drug delivery complexes and methods for their production |
CA2476755C (en) | 2001-12-17 | 2014-08-26 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of inflammatory bowel disease |
US20030204507A1 (en) | 2002-04-25 | 2003-10-30 | Li Jonathan Qiang | Classification of rare events with high reliability |
US20040053263A1 (en) | 2002-08-30 | 2004-03-18 | Abreu Maria T. | Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease |
DE60321027D1 (de) | 2002-10-25 | 2008-06-26 | Techlab Inc | Diagnostisches panel ibd-first chek fur entzundliche darmerkrankung (ibd) und reizkolon |
WO2004048600A2 (en) | 2002-11-22 | 2004-06-10 | Emory University | Diagnostic tests and methods for diagnosing inflammatory bowel disease |
US7662569B2 (en) | 2003-04-11 | 2010-02-16 | Cedars-Sinai Medical Center | Methods of assessing Crohn's disease patient phenotype by I2 serologic response |
JPWO2004095021A1 (ja) | 2003-04-23 | 2006-07-13 | エーザイ株式会社 | 疾患予後モデルの作成方法、このモデルを用いた疾患予後予測方法、このモデルによる予後予測装置、ならびにそのプログラム・記憶媒体 |
US20040242972A1 (en) | 2003-05-28 | 2004-12-02 | General Electric Company | Method, system and computer product for prognosis of a medical disorder |
US20050060295A1 (en) | 2003-09-12 | 2005-03-17 | Sensory Networks, Inc. | Statistical classification of high-speed network data through content inspection |
CA2549971A1 (en) | 2003-11-03 | 2005-05-12 | Duke University | Methods of identifying individuals at risk of perioperative bleeding, renal dysfunction or stroke |
WO2005078452A1 (en) | 2004-02-05 | 2005-08-25 | Medtronic, Inc. | Methods and apparatus for identifying patients at risk for life threatening arrhythmias |
US7759079B2 (en) | 2004-05-13 | 2010-07-20 | Prometheus Laboratories Inc. | Methods of diagnosing inflammatory bowel disease |
US20060154276A1 (en) * | 2004-05-13 | 2006-07-13 | Prometheus Laboratories Inc. | Methods of diagnosing inflammatory bowel disease |
US20060019410A1 (en) | 2004-07-21 | 2006-01-26 | Qualyst, Inc. | Apparatus, kits and methods for evaluating binding interactions, for detecting and quantifying binding molecules, and for sample preparation |
CA3204588A1 (en) | 2004-12-08 | 2006-06-15 | Cedars-Sinai Medical Center | Methods for diagnosis and treatment of crohn's disease |
US7873479B2 (en) | 2005-12-01 | 2011-01-18 | Prometheus Laboratories Inc. | Methods of diagnosing inflammatory bowel disease |
US20080085524A1 (en) * | 2006-08-15 | 2008-04-10 | Prometheus Laboratories Inc. | Methods for diagnosing irritable bowel syndrome |
US20100015156A1 (en) | 2007-03-06 | 2010-01-21 | Cedars-Sinai Medical Center | Diagnosis of inflammatory bowel disease in children |
US8153443B2 (en) | 2007-05-10 | 2012-04-10 | Cedars-Sinai Medical Center | Characterization of the CBir1 antigenic response for diagnosis and treatment of Crohn's disease |
CA2719384A1 (en) | 2008-03-27 | 2009-10-01 | Jx Nippon Oil & Energy Corporation | Fuel cell system and method for load following operation of the same |
CA2794757A1 (en) | 2008-11-11 | 2010-05-20 | Prometheus Laboratories Inc. | Methods for prediction of inflammatory bowel disease (ibd) using serologic markers |
EP2419529B1 (en) * | 2009-04-14 | 2015-05-20 | Nestec S.A. | Inflammatory bowel disease prognostics |
EP2778685B1 (en) * | 2009-06-25 | 2017-04-26 | Nestec S.A. | Methods for diagnosing irritable bowel syndrome |
BR112012012513A2 (pt) * | 2009-11-25 | 2017-01-10 | Prometheus Lab Inc | método para diagnosticar síndrome do intestino irritável em um paciente, método para monitorar a progressão ou regressão da síndrome do intestino irritável em um paciente, e para designar uma terapia contra síndrome do intestino irritável a um paciente em necessidade do mesmo |
JP2013528389A (ja) | 2010-06-04 | 2013-07-11 | ネステク ソシエテ アノニム | 炎症性腸疾患の診断を改善させる方法 |
-
2012
- 2012-10-19 EP EP12841790.4A patent/EP2769321B1/en active Active
- 2012-10-19 JP JP2014537335A patent/JP2015502740A/ja active Pending
- 2012-10-19 AU AU2012325798A patent/AU2012325798B2/en not_active Ceased
- 2012-10-19 WO PCT/US2012/061202 patent/WO2013059732A1/en active Application Filing
- 2012-10-19 SG SG11201401536QA patent/SG11201401536QA/en unknown
- 2012-10-19 CA CA2852954A patent/CA2852954A1/en not_active Abandoned
- 2012-10-19 MX MX2014004712A patent/MX352274B/es active IP Right Grant
-
2013
- 2013-03-15 US US13/840,779 patent/US8715943B2/en active Active
-
2014
- 2014-03-28 US US14/229,715 patent/US20150072879A1/en not_active Abandoned
- 2014-04-22 IL IL232167A patent/IL232167A0/en unknown
-
2015
- 2015-02-04 HK HK15101185.6A patent/HK1200933A1/zh not_active IP Right Cessation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109476698A (zh) * | 2016-05-20 | 2019-03-15 | 西达-赛奈医疗中心 | 基于基因的炎性肠病诊断 |
CN109476698B (zh) * | 2016-05-20 | 2023-10-17 | 西达-赛奈医疗中心 | 基于基因的炎性肠病诊断 |
Also Published As
Publication number | Publication date |
---|---|
EP2769321B1 (en) | 2016-06-01 |
IL232167A0 (en) | 2014-06-30 |
US8715943B2 (en) | 2014-05-06 |
EP2769321A4 (en) | 2015-05-13 |
SG11201401536QA (en) | 2014-05-29 |
US20130225439A1 (en) | 2013-08-29 |
MX352274B (es) | 2017-11-16 |
WO2013059732A1 (en) | 2013-04-25 |
EP2769321A1 (en) | 2014-08-27 |
CA2852954A1 (en) | 2013-04-25 |
AU2012325798B2 (en) | 2015-11-26 |
MX2014004712A (es) | 2014-11-14 |
US20150072879A1 (en) | 2015-03-12 |
JP2015502740A (ja) | 2015-01-29 |
AU2012325798A1 (en) | 2013-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1200933A1 (zh) | 改善炎性腸病診斷的方法 | |
IL269529A (en) | Methods for diagnosing and treating inflammatory bowel disease | |
HRP20190278T1 (hr) | Dijagnostički postupci za glaukom | |
IL222232A0 (en) | Circulating biomarkers for disease | |
PL2997901T3 (pl) | Sonda do obrazowania | |
EP2606353A4 (en) | CIRCULATING BIOMARKERS FOR DISEASE | |
WO2011153501A9 (en) | Methods for improving inflammatory bowel disease diagnosis | |
PT2787982T (pt) | Composição para preparação intestinal | |
HK1212220A1 (zh) | 與炎性腸病有關的抗原 | |
GB201008541D0 (en) | Diagnostic methods | |
ZA201302402B (en) | Methods for diagnosing lyme disease | |
EP2742358A4 (en) | METHOD FOR THE DIAGNOSIS OF CANCER | |
GB201011420D0 (en) | Method for diagnosis | |
GB201223223D0 (en) | Inflammatory bowel disease | |
IL227295A0 (en) | diagnostic method | |
AP2013007084A0 (en) | Diagnostic method | |
EP2543388A4 (en) | MEDICINAL PRODUCT FOR INFLAMMATORY ENDURANCE | |
EP2661625A4 (en) | DIAGNOSTIC PROCEDURE | |
NZ611793A (en) | Apparatus for disease detection | |
AP2013006853A0 (en) | Biomarker for vavular heart disease | |
GB201110712D0 (en) | Diagnostic methods | |
ZA201307890B (en) | Compositions and methods for treating diagnosing and monitoring disease | |
ZA201404276B (en) | Diagnostic methods | |
IL231330A0 (en) | Cancer diagnosis methods | |
GB201102301D0 (en) | Diagnostic methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20201021 |